News
It can be unusual for a husband and wife to be a transplant match because several factors are required, including blood and ...
5d
MedPage Today on MSNFaster, More Frequent Proteinuria Reduction With Sparsentan in FSGSPatients with focal segmental glomerulosclerosis (FSGS) achieved some degree of proteinuria remission more often and more ...
A post-hoc analysis of the DUPLEX trial shows significantly greater improvements in proteinuria-related outcomes vs irbesartan for tough-to-treat FSGS.
McDonald, from Escanaba, Michigan, told Newsweek that his mom, now 65, was born with a condition called Primary FSGS, which occurs without a known cause. According to the National Kidney ...
FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney condition and a leading cause of kidney failure Additionally, the FDA notified the Company that REMS ...
CEO Stephen Glover said, “ZyVersa is developing Cholesterol Efflux Mediator VAR 200 for treatment of chronic kidney diseases, initially ...
FSGS is a devastating, progressive, and complex rare kidney disorder affecting around 40,000 people in the US. It is a leading cause of kidney failure, requiring dialysis and transplant for survival.
FSGS is characterized by proteinuria ... Drugs that inhibit the renin-angiotensin system (RAS) can cause kidney injury. Patients whose kidney function may depend in part on the activity of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results